Characteristics of HPV infection over time in European women who are HIV-1 positive

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 120, Issue 1, 2013, Pages 41-49

  Heard, I ^a,b,c   Cubie, H A ^d   Mesher, D ^e   Sasieni, P ^e  

^a INSTITUT PASTEUR   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c INSERM   (France)

^d ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cohort study; HPV genotype distribution; HPV prevalence; screening; surveillance; women infected with HIV

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; COLPOSCOPY; CYTOLOGY; DISEASE COURSE; FEMALE; FOLLOW UP; GYNECOLOGIC CARE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; CD4 LYMPHOCYTE COUNT; CERVICAL INTRAEPITHELIAL NEOPLASIA; COINFECTION; DISEASE PROGRESSION; EUROPE; FEMALE; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84871218490     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/1471-0528.12015     Document Type: Article

References (22)

1. Frisch M, Biggar RJ, Goedert JJ,. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000; 92: 1500-10.
2. De Vuyst H, Lillo F, Broutet N, Smith JS,. HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy. Eur J Cancer Prev 2008; 17: 545-54.
3. Clifford GM, Gonçalves MAG, Franceschi S,. Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS 2006; 20: 2337-44. (Pubitemid 44789536)
4. Ahdieh L, Klein RS, Burk R, Cu-Uvin S, Schuman P, Duerr A, etal. Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis 2001; 184: 682-90. (Pubitemid 32826418)
5. Mocroft A, Phillips AN, Gatell J, Ledergerber B, Fisher M, Clumeck N, etal. Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study. Lancet 2007; 370: 407-13. (Pubitemid 47176633)
6. Kitchener H, Nelson L, Adams J, Mesher D, Sasieni P, Cubie H, etal. Colposcopy is not necessary to assess the risk to the cervix in HIV-positive women: an international cohort study of cervical pathology in HIV-1 positive women. Int J Cancer 2007; 121: 2484-91. (Pubitemid 350022418)
7. Denny L, Boa R, Williamson A, Allan B, Hardie D, Stan R, etal. Human papillomavirus infection and cervical disease in human immunodeficiency virus-1-infected women. Obstet Gynecol 2008; 111: 1380-7.
8. Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlée F, Hildesheim A, etal. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000; 38: 357-61. (Pubitemid 30043317)
9. Videla S, Darwich L, Cañadas MP, Paredes R, Tarrats A, Castella E, etal. Epidemiological data of different human papillomavirus genotypes in cervical specimens of HIV-1-infected women without history of cervical pathology. J Acquir Immune Defic Syndr 2009; 50: 168-75.
10. Theiler RN, Farr SL, Karon JM, Paramsothy P, Viscidi R, Duerr A, etal. High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral shedding. Obstet Gynecol 2010; 115: 1150-8.
11. Womack SD, Chirenje ZM, Gaffikin L, Blumenthal PD, McGrath JA, Chipato T, etal. HPV-based cervical cancer screening in a population at high risk for HIV infection. Int J Cancer 2000; 85: 206-10. (Pubitemid 30023069)
12. McKenzie ND, Kobetz EN, Hnatyszyn J, Twiggs LB, Lucci JA,. Women with HIV are more commonly infected with non-16 and -18 high-risk HPV types. Gynecol Oncol 2010; 116: 572-7.
13. Strickler HD, Palefsky JM, Shah KV, Anastos K, Klein RS, Minkoff H, etal. Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst 2003; 95: 1062-71. (Pubitemid 36950110)
14. Clifford GM, Smith JS, Aguado T, Franceschi S,. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 2003; 89: 101-5. (Pubitemid 36897943)
15. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, etal. A review of human carcinogens-Part B: biological agents. Lancet Oncol 2009; 10: 321-2.
16. Haas S, Park T, Voigt E, Büttner R, Merkelbach-Bruse S,. Detection of HPV 52, 58 and 87 in cervicovaginal intraepithelial lesions of HIV infected women. Int J Mol Med 2005; 16: 815-9.
17. Smits PHM, Bakker R, Jong E, Mulder JW, Meenhorst PL, Kleter B, etal. High prevalence of human papillomavirus infections in urine samples from human immunodeficiency virus-infected men. J Clin Microbiol 2005; 43: 5936-9. (Pubitemid 43100640)
18. Gagnon S, Hankins C, Money D, Pourreaux K, Franco E, Coutlée F,. Polymorphism of the L1 capsid gene and persistence of human papillomavirus type 52 infection in women at high risk or infected by HIV. J Acquir Immune Defic Syndr 2007; 44: 61-5. (Pubitemid 46052221)
19. Anastos K, Hoover DR, Burk RD, Cajigas A, Shi Q, Singh DK, etal. Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women. PLoS ONE 2010; 5: e13525.
20. Massad LS, Seaberg EC, Wright RL, Darragh T, Lee Y, Colie C, etal. Squamous cervical lesions in women with human immunodeficiency virus: long-term follow-up. Obstet Gynecol 2008; 111: 1388-93.
21. Minkoff H, Ahdieh L, Massad LS, Anastos K, Watts DH, Melnick S, etal. The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women. AIDS 2001; 15: 2157-64. (Pubitemid 33101823)
22. Heard I, Tassie J, Kazatchkine MD, Orth G,. Highly active antiretroviral therapy enhances regression of cervical intraepithelial neoplasia in HIV-seropositive women. AIDS 2002; 16: 1799-802.